PLAT and stroke disorder: The Food and Drug Administration (FDA) has only approved intravenous recombinant tissue plasminogen activator (IV rtPA) for treating IS (National Institute of Neurological Disorders and Stroke rt-Pa Stroke Study Group, 1995).